{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:03:19Z","timestamp":1790326999025,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"DOI":"10.1007\/s00246-026-04496-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:15:50Z","timestamp":1790324150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombolytic Use and Outcomes in Pediatric Congenital and Acquired Heart Disease: A Single-Center Quaternary Care Experience"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-4339","authenticated-orcid":false,"given":"Devika P.","family":"Richmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Murtagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva W.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"24","key":"4496_CR1","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","volume":"128","author":"TM Giglia","year":"2013","unstructured":"Giglia TM, Massicotte MP, Tweddell JS et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American heart association. Circulation 128(24):2622\u20132703. https:\/\/doi.org\/10.1161\/01.cir.0000436140.77832.7a","journal-title":"Circulation"},{"issue":"14","key":"4496_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1161\/CIRCULATIONAHA.110.006304","volume":"124","author":"C Manlhiot","year":"2011","unstructured":"Manlhiot C, Menjak IB, Brand\u00e3o LR et al (2011) Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation 124(14):1511\u20131519. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.006304","journal-title":"Circulation"},{"issue":"9","key":"4496_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.CIR.92.9.287","volume":"92","author":"DN Rosenthal","year":"1995","unstructured":"Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE (1995) Thromboembolic complications after fontan operations. Circulation 92(9):287\u2013293. https:\/\/doi.org\/10.1161\/01.CIR.92.9.287","journal-title":"Circulation"},{"issue":"1","key":"4496_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/pcsu.2002.29716","volume":"5","author":"P Monagle","year":"2002","unstructured":"Monagle P, Karl TR (2002) Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5(1):36\u201347. https:\/\/doi.org\/10.1053\/pcsu.2002.29716","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"issue":"4","key":"4496_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0022-5223(00)70010-9","volume":"119","author":"G Balling","year":"2000","unstructured":"Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J (2000) Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 119(4):745\u2013752. https:\/\/doi.org\/10.1016\/S0022-5223(00)70010-9","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4496_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jtcvs.2008.09.031","volume":"137","author":"KC Odegard","year":"2009","unstructured":"Odegard KC, Zurakowski D, DiNardo JA et al (2009) Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg 137(4):934\u2013941. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.09.031","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4496_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.106.652172","volume":"116","author":"JS Li","year":"2007","unstructured":"Li JS, Yow E, Berezny KY et al (2007) Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation 116(3):293\u2013297. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652172","journal-title":"Circulation"},{"issue":"4","key":"4496_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/S1047951100007150","volume":"8","author":"KAA Jubair","year":"1998","unstructured":"Jubair KAA, Fagih MRA, Jarallah ASA et al (1998) Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young 8(4):486\u2013490. https:\/\/doi.org\/10.1017\/S1047951100007150","journal-title":"Cardiol Young"},{"issue":"4","key":"4496_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.athoracsur.2017.06.043","volume":"104","author":"B Hobbes","year":"2017","unstructured":"Hobbes B, d\u2019Udekem Y, Zannino D, Konstantinov IE, Brizard C, Brink J (2017) Determinants of adverse outcomes after systemic-to-pulmonary shunts in biventricular circulation. Ann Thorac Surg 104(4):1365\u20131370. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.06.043","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4496_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43057-024-00131-3","volume":"32","author":"MH Mashali","year":"2024","unstructured":"Mashali MH, Elmahrouk AF, Ahmad Z et al (2024) Mechanical mitral valve endurance in children under 2 years. Cardiothorac Surg 32(1):12. https:\/\/doi.org\/10.1186\/s43057-024-00131-3","journal-title":"Cardiothorac Surg"},{"issue":"S1","key":"4496_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-10-S1-A81","volume":"10","author":"HJ Shin","year":"2015","unstructured":"Shin HJ, Jung JW, Park HK, Park YH (2015) Outcome of mechanical heart valve replacement in children: a 20-year experience. J Cardiothorac Surg 10(S1):A81. https:\/\/doi.org\/10.1186\/1749-8090-10-S1-A81","journal-title":"J Cardiothorac Surg"},{"issue":"8","key":"4496_CR12","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jvir.2014.04.003","volume":"25","author":"KU Kukreja","year":"2014","unstructured":"Kukreja KU, Lungren MP, Patel MN et al (2014) Endovascular venous thrombolysis in children younger than 24 months. J Vasc Interv Radiol 25(8):1158\u20131164. https:\/\/doi.org\/10.1016\/j.jvir.2014.04.003","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"4496_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jtcvs.2004.08.045","volume":"129","author":"R Kaulitz","year":"2005","unstructured":"Kaulitz R, Ziemer G, Rauch R et al (2005) Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). J Thorac Cardiovasc Surg 129(3):569\u2013575. https:\/\/doi.org\/10.1016\/j.jtcvs.2004.08.045","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4496_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00246-007-9140-9","volume":"29","author":"MA McCulloch","year":"2008","unstructured":"McCulloch MA, Conaway MR, Haizlip JA, Buck ML, Bovbjerg VE, Hoke TR (2008) Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses. Pediatr Cardiol 29(3):556\u2013561. https:\/\/doi.org\/10.1007\/s00246-007-9140-9","journal-title":"Pediatr Cardiol"},{"issue":"21","key":"4496_CR15","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2020.5269","volume":"323","author":"CC Muth","year":"2020","unstructured":"Muth CC (2020) Long-term outcomes after thrombolytic therapy for acute ischemic stroke. JAMA 323(21):2184. https:\/\/doi.org\/10.1001\/jama.2020.5269","journal-title":"JAMA"},{"issue":"11","key":"4496_CR16","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1161\/STROKEAHA.113.001938","volume":"44","author":"RG Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez RG, Furie KL, Goldmacher GV et al (2013) Good outcome rate of 35% in IV-tPA\u2013treated patients with computed tomography angiography confirmed severe anterior circulation occlusive stroke. Stroke 44(11):3109\u20133113. https:\/\/doi.org\/10.1161\/STROKEAHA.113.001938","journal-title":"Stroke"},{"issue":"1","key":"4496_CR17","doi-asserted-by":"publisher","first-page":"18F","DOI":"10.1136\/fn.85.1.F18","volume":"85","author":"J Hartmann","year":"2001","unstructured":"Hartmann J (2001) Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 85(1):18F \u2013 22. https:\/\/doi.org\/10.1136\/fn.85.1.F18","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"4496_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/STROKEAHA.114.008210","volume":"46","author":"MJ Rivkin","year":"2015","unstructured":"Rivkin MJ, deVeber G, Ichord RN et al (2015) Thrombolysis in pediatric stroke study. Stroke 46(3):880\u2013885. https:\/\/doi.org\/10.1161\/STROKEAHA.114.008210","journal-title":"Stroke"},{"issue":"3","key":"4496_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.chest.2021.09.019","volume":"161","author":"C Ross","year":"2022","unstructured":"Ross C, Kumar R, Pelland-Marcotte MC et al (2022) Acute management of high-risk and intermediate-risk pulmonary embolism in children. Chest 161(3):791\u2013802. https:\/\/doi.org\/10.1016\/j.chest.2021.09.019","journal-title":"Chest"},{"issue":"3","key":"4496_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4274\/jpr.galenos.2020.93206","volume":"8","author":"A Y\u00f6ntem","year":"2021","unstructured":"Y\u00f6ntem A, Leblebisatan G, Y\u0131ld\u0131zda\u015f D et al (2021) Evaluation of children receiving tissue plasminogen activator therapy for thrombosis: single center experience. J Pediatr Res 8(3):251\u2013256. https:\/\/doi.org\/10.4274\/jpr.galenos.2020.93206","journal-title":"J Pediatr Res"},{"issue":"5","key":"4496_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1067\/mpd.2001.118428","volume":"139","author":"AA Gupta","year":"2001","unstructured":"Gupta AA, Leaker M, Andrew M et al (2001) Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 139(5):682\u2013688. https:\/\/doi.org\/10.1067\/mpd.2001.118428","journal-title":"J Pediatr"},{"issue":"10","key":"4496_CR22","doi-asserted-by":"publisher","first-page":"e2538191","DOI":"10.1001\/jamanetworkopen.2025.38191","volume":"8","author":"PB Sporns","year":"2025","unstructured":"Sporns PB, Bhatia KD, Muthusami P et al (2025) Intravenous thrombolysis for pediatric acute ischemic stroke. JAMA Netw Open 8(10):e2538191. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.38191","journal-title":"JAMA Netw Open"},{"issue":"2","key":"4496_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/STROKEAHA.119.027225","volume":"51","author":"C Amlie-Lefond","year":"2020","unstructured":"Amlie-Lefond C, Shaw DWW, Cooper A et al (2020) Risk of intracranial hemorrhage following intravenous tPA (Tissue-type plasminogen activator) for acute stroke is low in children. Stroke 51(2):542\u2013548. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027225","journal-title":"Stroke"},{"issue":"07","key":"4496_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0037-1613170","volume":"88","author":"M Manco-Johnson","year":"2002","unstructured":"Manco-Johnson M, Grabowski EF, Hellgreen M et al (2002) Recommendations for tPA thrombolysis in children: on behalf of the scientific subcommittee on perinatal and pediatric thrombosis of the scientific and standardization committee of the international society of thrombosis and haemostasis. Thromb Haemost 88(07):157\u2013158. https:\/\/doi.org\/10.1055\/s-0037-1613170","journal-title":"Thromb Haemost"},{"key":"4496_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000183","author":"DM Ferriero","year":"2019","unstructured":"Ferriero DM, Fullerton HJ, Bernard TJ et al (2019) Management of stroke in neonates and children: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. https:\/\/doi.org\/10.1161\/STR.0000000000000183","journal-title":"Stroke"},{"issue":"22","key":"4496_CR26","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","volume":"2","author":"P Monagle","year":"2018","unstructured":"Monagle P, Cuello CA, Augustine C et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2(22):3292\u20133316. https:\/\/doi.org\/10.1182\/bloodadvances.2018024786","journal-title":"Blood Adv"},{"issue":"3","key":"4496_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0256-4947.62840","volume":"30","author":"AS Al-Jazairi","year":"2010","unstructured":"Al-Jazairi AS, Al-Gain RA, Bulbul ZR, Cherfan AJ (2010) Clinical experience with alteplase in the management of intracardiac and major cardiac vessels thrombosis in pediatrics: a case series. Ann Saudi Med 30(3):227\u2013232. https:\/\/doi.org\/10.4103\/0256-4947.62840","journal-title":"Ann Saudi Med"},{"issue":"5","key":"4496_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ccd.24521","volume":"82","author":"A Bratincs\u00e1k","year":"2013","unstructured":"Bratincs\u00e1k A, Moore JW, El-Said HG (2013) Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: A single center experience. Catheter Cardiovasc Interv 82(5):782\u2013785. https:\/\/doi.org\/10.1002\/ccd.24521","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"4496_CR29","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s00246-015-1199-0","volume":"36","author":"M El-Segaier","year":"2015","unstructured":"El-Segaier M, Khan MA, Khan ZU, Momenah T, Galal MO (2015) Recombinant tissue plasminogen activator in the treatment of neonates with intracardiac and great vessels thrombosis. Pediatr Cardiol 36(8):1582\u20131587. https:\/\/doi.org\/10.1007\/s00246-015-1199-0","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"4496_CR30","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00246-012-0446-x","volume":"34","author":"EW Cheung","year":"2013","unstructured":"Cheung EW, Aponte-Patel L, Bacha EA, Singh RK, Rosenzweig EB, Sen AI (2013) Successful treatment of severe mechanical mitral valve thrombosis with tissue plasminogen activator in a 7-month-old infant. Pediatr Cardiol 34(8):1903\u20131907. https:\/\/doi.org\/10.1007\/s00246-012-0446-x","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"4496_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0167-5273(92)90229-V","volume":"35","author":"A Asante-Korang","year":"1992","unstructured":"Asante-Korang A, Sreeram N, McKay R, Arnold R (1992) Thrombolysis with tissue-type plasminogen activator following cardiac surgery in children. Int J Cardiol 35(3):317\u2013322. https:\/\/doi.org\/10.1016\/0167-5273(92)90229-V","journal-title":"Int J Cardiol"},{"key":"4496_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2015.11.020","volume":"171","author":"DA Ansah","year":"2016","unstructured":"Ansah DA, Patel KN, Montegna L, Nicholson GT, Ehrlich AC, Petit CJ (2016) Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. J Pediatr 171:67-72e2. https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.020","journal-title":"J Pediatr"},{"issue":"5","key":"4496_CR33","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1097\/MPH.0000000000002031","volume":"43","author":"E Pekpak","year":"2021","unstructured":"Pekpak E, \u0130nce E, Ertem M et al (2021) Tissue plasminogen activator use in pediatric patients: a single center experience. J Pediatr Hematol Oncol 43(5):e648\u2013e651. https:\/\/doi.org\/10.1097\/MPH.0000000000002031","journal-title":"J Pediatr Hematol Oncol"},{"key":"4496_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fped.2017.00260","volume":"5","author":"C Tarango","year":"2017","unstructured":"Tarango C, Manco-Johnson MJ (2017) Pediatric thrombolysis: a practical approach. Front Pediatr 5:260. https:\/\/doi.org\/10.3389\/fped.2017.00260","journal-title":"Front Pediatr"},{"key":"4496_CR35","doi-asserted-by":"publisher","unstructured":"The Fibrinolytic System in Children (2003) Semin thromb hemost 29(4):339\u2013348. https:\/\/doi.org\/10.1055\/s-2003-42585","DOI":"10.1055\/s-2003-42585"},{"key":"4496_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2016.01.016","volume":"56","author":"MJ Rivkin","year":"2016","unstructured":"Rivkin MJ, Bernard TJ, Dowling MM, Amlie-Lefond C (2016) Guidelines for urgent management of stroke in children. Pediatr Neurol 56:8\u201317. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.01.016","journal-title":"Pediatr Neurol"},{"issue":"4","key":"4496_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4274\/tjh.galenos.2021.2021.0038","volume":"38","author":"E Zengin","year":"2021","unstructured":"Zengin E, Sarper N, Yazal Erdem A et al (2021) Thrombolysis with systemic recombinant tissue plasminogen activator in children: a multicenter retrospective study. Turk J Haematol 38(4):294\u2013305. https:\/\/doi.org\/10.4274\/tjh.galenos.2021.2021.0038","journal-title":"Turk J Haematol"},{"key":"4496_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200305000-00006","author":"M Wang","year":"2003","unstructured":"Wang M, Hays T, Balasa V et al (2003) Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. https:\/\/doi.org\/10.1097\/00043426-200305000-00006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"4496_CR39","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1161\/STROKEAHA.122.039652","volume":"53","author":"M Romoli","year":"2022","unstructured":"Romoli M, Vandelli L, Bigliardi G et al (2022) Fibrinogen depletion coagulopathy predicts major bleeding after thrombolysis for ischemic stroke: a multicenter study. Stroke 53(12):3671\u20133678. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039652","journal-title":"Stroke"},{"issue":"5","key":"4496_CR40","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jvs.2016.11.025","volume":"65","author":"MHF Poorthuis","year":"2017","unstructured":"Poorthuis MHF, Brand EC, Hazenberg CEVB et al (2017) Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusions. J Vasc Surg 65(5):1519\u20131527e26. https:\/\/doi.org\/10.1016\/j.jvs.2016.11.025","journal-title":"J Vasc Surg"},{"issue":"7","key":"4496_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1538574413497107","volume":"47","author":"N Skeik","year":"2013","unstructured":"Skeik N, Gits CC, Ehrenwald E, Cragg AH (2013) Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Vasc Endovascular Surg 47(7):519\u2013523. https:\/\/doi.org\/10.1177\/1538574413497107","journal-title":"Vasc Endovascular Surg"},{"issue":"3","key":"4496_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/1941874415578532","volume":"5","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA (2015) Absolute and relative contraindications to IV rt-PA for Acute ischemic stroke. Neurohospitalist 5(3):110\u2013121. https:\/\/doi.org\/10.1177\/1941874415578532","journal-title":"Neurohospitalist"},{"key":"4496_CR43","unstructured":"Hacke W, Ringleb PA, Bousser MG, Ford G, Bath P, Brainin M, Caso V, Cervera A, Chamorro A, Cordonnier C (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008-The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovasc Dis 25(5):457-507."},{"issue":"6","key":"4496_CR44","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/01.STR.32.6.1365","volume":"32","author":"JA Chalela","year":"2001","unstructured":"Chalela JA, Katzan I, Liebeskind DS et al (2001) Safety of intra-arterial thrombolysis in the postoperative period. Stroke 32(6):1365\u20131369. https:\/\/doi.org\/10.1161\/01.STR.32.6.1365","journal-title":"Stroke"},{"issue":"2","key":"4496_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.amjcard.2010.09.013","volume":"107","author":"S Keuleers","year":"2011","unstructured":"Keuleers S, Herijgers P, Herregods MC et al (2011) Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis. Am J Cardiol 107(2):275\u2013279. https:\/\/doi.org\/10.1016\/j.amjcard.2010.09.013","journal-title":"Am J Cardiol"},{"issue":"10","key":"4496_CR46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2021.12.027","volume":"79","author":"M \u00d6zkan","year":"2022","unstructured":"\u00d6zkan M, G\u00fcnd\u00fcz S, G\u00fcner A et al (2022) Thrombolysis or surgery in patients with obstructive mechanical valve thrombosis. J Am Coll Cardiol 79(10):977\u2013989. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.027","journal-title":"J Am Coll Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04496-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:15:53Z","timestamp":1790324153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04496-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":46,"alternative-id":["4496"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04496-6","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}